Tirzepatide Dosing for Weight Loss: A Complete Guide to the Titration Schedule

If you've been prescribed tirzepatide for weight loss, the dosing schedule can feel confusing. Why start so low? When do you step up? What if a dose feels like too much? This guide walks through how tirzepatide dosing usually works, why titration matters, and what to expect at each step. It's educational — your own plan should always come from your clinician.

What is tirzepatide and how does it support weight loss?

Tirzepatide is a once-weekly injection that activates two gut hormone receptors: the GLP-1 receptor and the GIP receptor. Together, these signals slow how fast your stomach empties, lower appetite, and help regulate blood sugar [1]. The result, for many people, is feeling full sooner, getting hungry less often, and a steadier relationship with food.

Tirzepatide is sold under two brand names. Zepbound is FDA-approved for chronic weight management in adults who meet specific BMI criteria, and Mounjaro is approved for type 2 diabetes [2][3]. The active ingredient is the same in both, but using Mounjaro for weight loss without diabetes is considered off-label.

FDA-approved tirzepatide doses for weight loss (Zepbound)

Zepbound is available in six strengths. The lower two (2.5 mg and 7.5 mg) are titration doses — meant as stepping stones, not destinations. The other four (5 mg, 10 mg, and 15 mg, plus the 12.5 mg titration option) can be used as maintenance doses [2].

Tirzepatide titration schedule

"Titration" just means starting low and slowly working up. Tirzepatide is titrated because the digestive system needs time to adapt to slower stomach emptying. Going up too fast is the main reason people experience strong nausea or vomiting [2].

Starting dose (2.5 mg)

Everyone starts at 2.5 mg once weekly for the first four weeks. This dose is not expected to produce major weight loss on its own — it's there to let your body get used to the medication [2]. Many people feel mild nausea, fullness, or fatigue during this window.

Dose escalation every 4 weeks

After the starter month, the dose can be increased by 2.5 mg every four weeks if you're tolerating it well. A typical path looks like 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg [2]. Most people don't need to climb the whole ladder; many find their right dose at 5 or 10 mg.

Maintenance doses (5, 10, and 15 mg)

The maintenance dose is the level you stay on long-term. The FDA-approved maintenance doses are 5 mg, 10 mg, and 15 mg [2]. In the SURMOUNT-1 clinical trial, average weight loss after 72 weeks was about 15% at 5 mg, 19.5% at 10 mg, and 20.9% at 15 mg, alongside diet and exercise [4]. Higher doses tend to produce more weight loss on average, but also more side effects.

How to choose your maintenance dose

There's no single "best" maintenance dose. Your clinician will weigh things like:

• How well you're losing weight at the current dose
• How you're tolerating side effects
• Other health conditions and medications
• Your weight-loss goals and timeline
• Cost and supply considerations

If you're losing weight steadily and feeling well at 5 mg, there may be no reason to go higher. If progress stalls and side effects are mild, your clinician may suggest stepping up. The goal is the lowest effective dose that gets you to your health targets.

How tirzepatide is injected

Tirzepatide is given as a subcutaneous injection — just under the skin — once a week, on the same day each week. Common injection sites are the abdomen, thigh, or upper arm. You can rotate sites and inject at any time of day, with or without food [2]. If you need to change your weekly injection day, the new day should be at least 3 days (72 hours) after your last dose.

What to do if you miss a dose

According to the FDA label, if you miss a dose, take it as soon as possible within 4 days (96 hours) of the missed dose. If more than 4 days have passed, skip the missed dose and take the next one on your regular weekly schedule [2]. Don't take two doses close together to catch up.

Side effects by dose and how to manage them

The most common side effects of tirzepatide are gastrointestinal: nausea, diarrhea, constipation, vomiting, abdominal pain, and indigestion [2][4]. These are usually mild to moderate and tend to peak in the first 1–2 weeks after starting a new dose, then fade as your body adapts.

Some general patterns reported in clinical trials:

• Nausea was the most common side effect overall, affecting roughly 25–33% of participants across doses in SURMOUNT-1 [4].
• Higher doses had somewhat higher rates of GI side effects, but most people who experienced side effects were able to continue treatment [4].
• Serious side effects are uncommon but include pancreatitis, gallbladder disease, kidney problems from dehydration, and hypoglycemia (low blood sugar) — the last is more likely if you also take insulin or sulfonylureas [2].

Practical ways people manage mild GI symptoms include eating smaller meals, going easy on greasy or very sweet foods, staying hydrated, and adding fiber for constipation. If symptoms are severe, persistent, or alarming (severe abdominal pain, repeated vomiting, signs of dehydration), contact your clinician promptly.

When your provider may slow or pause titration

The 4-week step-up schedule is a guideline, not a rule. The FDA label allows clinicians to delay a dose increase by another 4 weeks if side effects haven't settled [2]. Reasons a clinician might slow things down or hold a dose include:

• Ongoing nausea or vomiting that affects eating or hydration
• Significant weight loss already happening at the current dose
• Signs of dehydration or kidney strain
• Suspected pancreatitis or gallbladder problems
• Pregnancy or planning pregnancy (tirzepatide should be stopped)
• A planned surgery or procedure requiring fasting

Slowing down isn't failure. Many people do better long-term on a lower, well-tolerated dose than on the maximum dose with constant side effects.

Tirzepatide vs. semaglutide dosing at a glance

Semaglutide (sold as Wegovy for weight loss and Ozempic for diabetes) is the other widely used GLP-1 medication. It works on one receptor (GLP-1), while tirzepatide works on two (GLP-1 and GIP) [1][5]. Both are weekly injections that are titrated up over months.

Neither medication is universally "better." The right choice depends on your health profile, side-effect tolerance, insurance coverage, and clinician's judgment.

Frequently asked questions

This article was written with AI assistance and reviewed by a member of Chia's clinical team for accuracy and balance.

Keep reading

GLP-1 Medications

Semaglutide for Weight Loss: How It Works, Results, and Who Qualifies

GLP-1 Weight Loss

Semaglutide Dose for Weight Loss: A Step-by-Step Guide

GLP-1 Basics

Ozempic vs. Wegovy vs. Mounjaro vs. Zepbound: The 2026 GLP-1 comparison